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CTS-induced RAS activation resulted in c-Raf phosphorylation. However,
c-Raf activation was not mediated via PAK phosphorylation and was not
inhibited by LY294002. These results suggested that RAS activated c-Raf
directly without PI-3-kinase mediated PAK-1 activation. CTS induced
c-RAF activation was followed by MEK1/2 (Ser217/221) phosphorylation,
which in turn phosphorylated ERK 1/2. Interestingly, Il-1b induced ERK
activation was mediated by RAS GTPase activity, however, its activation
cascade was distinct from CTS induced ERK1/2 activation. Examination
of down stream events revealed that in parallel to ERK activation, CTS
induced an increase in c-Myc phosphorylation and upregulation of c-myc,
VEGF, ERK 1/2, aggrecan, gene transcription. Furthermore, inhibition
of MEK1 by PD98059 inhibited CTS-induced upregulation of c-myc and
VEGF mRNA expression.
Conclusions: The results demonstrate that the anabolic actions of me-
chanical signals, at least in part, are mediated via ERK signaling cascade.
Furthermore, CTS upregulated RAS GTPase activity to initiate ERK
signaling cascade that results in the induction of genes such as VEGF
and c-myc that are associated with chondrocyte growth and proliferation.
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Purpose: One hallmark of osteoarthritis is erosion of the articular carti-
lage surface. In adult human knee articular cartilage, surface roughening
is associated with the weakening of cartilage both in ageing and in age-
matched samples. In addition, synovial ﬂuid (SF) exhibits concentration-
dependent lubrication qualities for articulating cartilage. Previously, stud-
ies of ex vivo joint wear have involved complex joint geometries and non-
physiological loading, and in vitro tissue wear has been limited to cartilage
apposition against a material such as steel. The hypothesis of this study
was that wear of articulating cartilage, under physiologically-motivated
loading amplitudes and patterns, increases with the number of loading
cycles, decreasing concentration of SF lubricant, and surface ﬁbrillation.
Methods: Experiments were performed to assess the effects of number
of loading cycles, decreasing concentration of SF lubricant, and cartilage
surface ﬁbrillation on the wear of articulating cartilage. For each experi-
ment, the loading protocol was 1 MPa compressive stress and ±15mm
sliding at 1800 cycles/hr for 4 or 8 hr with n = 3−4/group. To assess
the direct mechanical effects on wear, test lubricants were spiked with
protease inhibitors to inhibit enzymatic activity (anabolic and catabolic)
without affecting boundary lubrication. The wear-induced decrease in
cartilage thickness and loss of glycosaminoglycan (GAG) and collagen
(COL) into the lubricant was determined, and results analyzed statistically
with ANOVA. (1) The effect of loading cycles was assessed with bovine
samples tested in bovine SF or PBS as lubricant. (2) The effect of SF
concentration was determined with bovine samples tested in SF at 100%
or diluted to 30, 10, or 0% in PBS. (3) The effect of cartilage ﬁbrillation was
assessed with human samples with articular surfaces that were normal
(NL) or mildly degenerate (DGN) and with SF or PBS lubricant.
Results:
1. Cartilage thickness decreased with loading cycles, with more erosion
for samples lubricated with PBS (+260%) than with SF. The rate of
GAG and COL loss into PBS occurred in a linear fashion, 0.0027%/cy-
cle (R2=0.98) and 0.00042%/cycle (R2=0.99), respectively. SF lubri-
cant decreased the loss of GAG (−152%) and COL (−377%) compared
to PBS lubricant.
2. Wear increased with decreasing concentrations of SF. Cartilage thick-
ness decrease was 15% with 100% or 30% SF, and increased to
53% (+236% increase above 100% SF) with 10% SF and to 56%
(+256%) with 0% SF. Similarly, GAG loss and COL loss, relative to
that when lubricated with 100% SF, was higher when lubricated with
30% SF (+64% and +100%), 10% SF (+227% and +233%), and 0%
SF (+245% and +250%).
3. Cartilage wear was also dependent on the tissue integrity. The thick-
ness decrease, GAG loss, and COL loss were greater in DGN than NL
samples (+622%, +284%, and +190%), and when lubricated by PBS
rather than SF (+206%, +165%, and +91%).
Conclusions: These studies indicate that altered lubrication and carti-
lage ﬁbrillation, both, are important factors in the mechanical wear of
articulating cartilage. The mechanisms by which SF is wear-protective
may involve boundary lubrication to lower wear directly or, indirectly, by
lowering friction-induced tissue shear. The increased wear of cartilage
with ﬁbrillation may reﬂect increased shear strain of the collagen network
in the superﬁcial region. Enhancement of SF lubrication may be a biome-
chanical treatment strategy for patients with early or established cartilage
degeneration.
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Purpose: Meniscus loss leads to decreased clinical function and activity
levels and increases the rate of knee degeneration, thus leading to
additional surgeries or even knee replacement, especially in chronic
patients. Chronic patients are more focused on preserving their knees and
avoiding additional surgeries. The purpose of this study was to determine
if replacement of lost or irreparable meniscus tissue with the Collagen
Meniscus Implant (CMI) decreased the need for additional surgeries in
multiply operated chronic knee patients compared to meniscectomy only.
We hypothesized that patients who gained meniscus tissue with the CMI
would require fewer surgeries than meniscectomy only controls through
ﬁve years.
Methods: In this prospective randomized multicenter clinical trial (Level
of Evidence I), patients 18 to 60 years old who had undergone one
to three prior partial medial meniscectomies and currently had clinical
symptoms of meniscus pathology were randomized either to receive the
CMI or have an additional partial meniscectomy (control). Eighty-ﬁve
CMI were implanted, but one was removed at 3weeks after an incision
wound infection and two patients died. The remaining 82 CMI patients
were compared to 66 controls over 5 years to determine survivorship.
Survivorship was deﬁned as not having an additional unplanned surgery
outside the experimental protocol on the study knee.
Results: Follow-up rate at 5 years was 96%. Eight CMI patients (9.5%)
and 15 control patients (22.7%) required reoperation through 5 years.
Survivorship at one year was 90% for control and 95% for CMI patients,
86% for control and 95% for CMI patients at 2 years, 83% and 92% at
3 years, 79% for control patients and 91% for CMI patients at 4 years, and
74% for control patients and 89% for CMI patients at 5 years. CMI patients
had a signiﬁcantly higher survivorship compared to controls (p = 0.04).
The risk (odds) of reoperation was 2.7 times greater for controls compared
to CMI patients at 5 years (95%CI = 1.2 to 6.7). Furthermore, the majority
of control patient reoperations occurred prior to 24 months, but only four
CMI reoperations occurred during the ﬁrst 24 months (Figure).
Conclusions: This study conﬁrms that chronic patients who received
the CMI required fewer additional surgeries in their multiply operated
